ZA200608569B - Polymorphic forms of methyl (+)-(S)-alpha- (2-chlorophenyl)-6, 7-dinydrothieno[3,2-C] pyridine-5(4H) acetate hydrobromide, clopidrogel hydrobromide - Google Patents
Polymorphic forms of methyl (+)-(S)-alpha- (2-chlorophenyl)-6, 7-dinydrothieno[3,2-C] pyridine-5(4H) acetate hydrobromide, clopidrogel hydrobromideInfo
- Publication number
- ZA200608569B ZA200608569B ZA200608569A ZA200608569A ZA200608569B ZA 200608569 B ZA200608569 B ZA 200608569B ZA 200608569 A ZA200608569 A ZA 200608569A ZA 200608569 A ZA200608569 A ZA 200608569A ZA 200608569 B ZA200608569 B ZA 200608569B
- Authority
- ZA
- South Africa
- Prior art keywords
- hydrobromide
- dinydrothieno
- chlorophenyl
- pyridine
- alpha
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56379604P | 2004-04-20 | 2004-04-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200608569B true ZA200608569B (en) | 2007-12-27 |
Family
ID=34966201
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200608569A ZA200608569B (en) | 2004-04-20 | 2005-04-18 | Polymorphic forms of methyl (+)-(S)-alpha- (2-chlorophenyl)-6, 7-dinydrothieno[3,2-C] pyridine-5(4H) acetate hydrobromide, clopidrogel hydrobromide |
Country Status (20)
Country | Link |
---|---|
US (1) | US20070088049A1 (es) |
EP (1) | EP1756116A1 (es) |
JP (1) | JP2007533744A (es) |
KR (1) | KR20070012675A (es) |
CN (1) | CN1997648A (es) |
AU (1) | AU2005236034A1 (es) |
BR (1) | BRPI0509997A (es) |
CA (1) | CA2562507A1 (es) |
CR (1) | CR8678A (es) |
EA (1) | EA010831B1 (es) |
EC (1) | ECSP066932A (es) |
IL (1) | IL178680A0 (es) |
MA (1) | MA28588B1 (es) |
MX (1) | MXPA06012205A (es) |
NO (1) | NO20065233L (es) |
NZ (1) | NZ551371A (es) |
TN (1) | TNSN06331A1 (es) |
UA (1) | UA83919C2 (es) |
WO (1) | WO2005103058A1 (es) |
ZA (1) | ZA200608569B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0321256D0 (en) | 2003-09-11 | 2003-10-08 | Generics Uk Ltd | Novel crystalline compounds |
EP1704152A2 (en) * | 2004-09-21 | 2006-09-27 | Teva Pharmaceutical Industries Ltd | Crystalline clopidogrel hydrobromide and processes for preparation thereof |
SI22492A (sl) * | 2007-03-08 | 2008-10-31 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Polimorfne oblike klopidogrel hidrobromida |
PE20091156A1 (es) * | 2007-12-17 | 2009-09-03 | Astrazeneca Ab | Sales de (3-{[[3-(6-amino-2-butoxi-8-oxo-7,8-dihidro-9h-purin-9-il)propil](3-morfolin-4-ilpropil)amino]metil}fenil)acetato de metilo |
ES2376057T3 (es) * | 2008-02-26 | 2012-03-08 | Laboratorios Lesvi, S.L. | Formulaciones farmacéuticas que contienen clopidogrel. |
HUP1400294A2 (hu) | 2014-06-13 | 2015-12-28 | Skillpharm Kft | Clopidogrel új alkalmazása |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2623810B2 (fr) * | 1987-02-17 | 1992-01-24 | Sanofi Sa | Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant |
FR2779726B1 (fr) * | 1998-06-15 | 2001-05-18 | Sanofi Sa | Forme polymorphe de l'hydrogenosulfate de clopidogrel |
WO2001039775A1 (en) * | 1999-12-06 | 2001-06-07 | Euro-Celtique, S.A. | Benzimidazole compounds having nociceptin receptor affinity |
IL162461A0 (en) * | 2001-12-18 | 2005-11-20 | Teva Pharma | Polymorphs of clopidogrel hydrogensulfate |
US7074928B2 (en) * | 2002-01-11 | 2006-07-11 | Teva Pharmaceutical Industries, Ltd. | Polymorphs of clopidogrel hydrogensulfate |
HUP0200438A3 (en) * | 2002-02-06 | 2003-10-28 | Egis Gyogyszergyar Nyilvanosan | Novel clopidogrel hydrochloride polymorphs, process for the preparation thereof, their use and pharmaceutical compositions containing them |
CZ297472B6 (cs) * | 2002-08-27 | 2006-12-13 | Zentiva, A.S. | Zpusob výroby clopidogrelu hydrogensulfátu krystalické formy I |
DE10305984A1 (de) * | 2003-02-13 | 2004-09-02 | Helm Ag | Salze organischer Säuren mit Clopidogrel und deren Verwendung zur Herstellung phamazeutischer Formulierungen |
GB0321256D0 (en) * | 2003-09-11 | 2003-10-08 | Generics Uk Ltd | Novel crystalline compounds |
GB0325603D0 (en) * | 2003-11-03 | 2003-12-10 | Sandoz Ag | Organic compounds |
EA008972B1 (ru) * | 2004-01-13 | 2007-10-26 | Зентива А.С. | Новые кристаллические формы гидробромида клопидогреля и способы их получения |
CN1922188A (zh) * | 2004-02-24 | 2007-02-28 | 齐格弗里德通用国际股份公司 | 氯吡格雷之药学可接受的盐 |
-
2005
- 2005-04-18 ZA ZA200608569A patent/ZA200608569B/xx unknown
- 2005-04-18 AU AU2005236034A patent/AU2005236034A1/en not_active Abandoned
- 2005-04-18 KR KR1020067021700A patent/KR20070012675A/ko not_active Application Discontinuation
- 2005-04-18 EA EA200601921A patent/EA010831B1/ru not_active IP Right Cessation
- 2005-04-18 CN CNA2005800118591A patent/CN1997648A/zh active Pending
- 2005-04-18 MX MXPA06012205A patent/MXPA06012205A/es not_active Application Discontinuation
- 2005-04-18 WO PCT/US2005/013146 patent/WO2005103058A1/en active Application Filing
- 2005-04-18 BR BRPI0509997-8A patent/BRPI0509997A/pt not_active IP Right Cessation
- 2005-04-18 JP JP2007509543A patent/JP2007533744A/ja active Pending
- 2005-04-18 NZ NZ551371A patent/NZ551371A/en unknown
- 2005-04-18 EP EP05736220A patent/EP1756116A1/en not_active Withdrawn
- 2005-04-18 UA UAA200612105A patent/UA83919C2/ru unknown
- 2005-04-18 CA CA002562507A patent/CA2562507A1/en not_active Abandoned
-
2006
- 2006-10-09 CR CR8678A patent/CR8678A/es not_active Application Discontinuation
- 2006-10-13 TN TNP2006000331A patent/TNSN06331A1/en unknown
- 2006-10-17 IL IL178680A patent/IL178680A0/en unknown
- 2006-10-17 EC EC2006006932A patent/ECSP066932A/es unknown
- 2006-10-19 US US11/550,891 patent/US20070088049A1/en not_active Abandoned
- 2006-11-14 NO NO20065233A patent/NO20065233L/no not_active Application Discontinuation
- 2006-11-20 MA MA29464A patent/MA28588B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
AU2005236034A1 (en) | 2005-11-03 |
BRPI0509997A (pt) | 2007-10-16 |
EA200601921A1 (ru) | 2007-02-27 |
MXPA06012205A (es) | 2007-01-31 |
NO20065233L (no) | 2006-11-14 |
TNSN06331A1 (en) | 2008-02-22 |
EA010831B1 (ru) | 2008-12-30 |
CA2562507A1 (en) | 2005-11-03 |
IL178680A0 (en) | 2007-02-11 |
UA83919C2 (en) | 2008-08-26 |
EP1756116A1 (en) | 2007-02-28 |
CN1997648A (zh) | 2007-07-11 |
US20070088049A1 (en) | 2007-04-19 |
ECSP066932A (es) | 2006-12-20 |
MA28588B1 (fr) | 2007-05-02 |
WO2005103058A1 (en) | 2005-11-03 |
NZ551371A (en) | 2010-07-30 |
KR20070012675A (ko) | 2007-01-26 |
JP2007533744A (ja) | 2007-11-22 |
CR8678A (es) | 2007-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200504238B (en) | Thieno[3,2-b]pyridine-6-carbonitriles and thienoo[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors | |
HK1098480A1 (en) | Method of preparing thieno [3,2-c]pyridine derivatives and intermediates used therein | |
IL208249A0 (en) | Spirocyclic heterocyclic derivatives and methods of their use | |
ZA200608569B (en) | Polymorphic forms of methyl (+)-(S)-alpha- (2-chlorophenyl)-6, 7-dinydrothieno[3,2-C] pyridine-5(4H) acetate hydrobromide, clopidrogel hydrobromide | |
AU2003251247A1 (en) | Methods for preparation of olanzapine polymorphic form i | |
ZA200802690B (en) | Thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors | |
DK1635839T3 (da) | Benzo[4,5]thieno[2,3-D]pyrimidin-4-oner og deres terapeutiske anvendelse | |
IL189667A0 (en) | 4-amino-thieno[3,2-c]pyridine-7-carboxylic acid derivatives | |
IL178019A0 (en) | METHODS FOR THE PREPARATION OF (3R,3aS,6aR)HEXAHYDRO-FURO[2,3-b]FURAN-3OL | |
IL181867A0 (en) | Crystalline clopidogrel hydrobromide and processes for preparation thereof | |
EP1625111A4 (en) | THYRONAMINE DERIVATIVES AND ANALOGUES AND METHODS OF USE THEREOF | |
AU2003211047A8 (en) | Method of preparation of 21-amino epothilone derivatives | |
UA84335C2 (ru) | Клопидогрель и его полиморфные формы | |
ZA201000627B (en) | 2-(2-oxoindoline-3-ylidene)methyl-5-(2-hydroxy-3-morpholin-4-yl-propyl)-6,7-dihydro-1h-pyrrol[3,2-c]pyridine-4(5h)-one compounds and use as protein kinase inhibitors | |
PL357928A1 (en) | Method of obtaining pharmaceutically pure polymorphic form of i olanzapine | |
HU0600194D0 (en) | Process for producing (s)-(+)-methyl-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4h)-acetate hidrogen sulfate polimorph i | |
HUP0402152A3 (en) | Preparation of trans-fused 3,3a,8,12b-tetrahydro-2h-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivatives | |
SG113595A1 (en) | New benzo[b]chromeno-naphthyridin-7-one and pyrano[2',3':7,8] quino[2,3-b]quinoxalin-7-one compounds, process for their preparation and pharmaceutical compositions containing them | |
ZA200605930B (en) | Crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxyl}ethyl}-6H-dipyrido[3,2-B:2',3'-e][1,4]diazepin-6-one | |
IL175957A0 (en) | Novel crystalline forms of 2,3 dimethyl-8-(2,6-dimethylbenzylamino)-n-hydroxyethyl-imidazo[1,2-a] pyridine-6-carboxamide mesylate salt | |
WO2008108742A3 (en) | Polymorphic forms of clopidogrel hydrobromide | |
HU0700809D0 (en) | Racemisation process for producing methyl (r,s)-(+)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridin-5(4h)-acetate hydrogene sulfate intermediate | |
PL380849A1 (pl) | Krystaliczna postać racemicznego -(2-chlorofenylo)-6,7-dihydrotieno[3,2-c]pirydylo-5(4H)-octanu metylu, sposób jej wytwarzania i zastosowanie | |
PL376058A1 (pl) | Nowe pochodne 8-chloro-5,5-dioksoimidazo[1,2-b][1,4,2]benzoditiazyny i sposób ich otrzymywania | |
DK1392698T3 (da) | Fremgangsmåde til fremstilling af 6-aryl-4H-s-triazolo-[3,4-c]thieno[2,3-e]-1,4-diazepiner |